Ebola/EVD: Vaccines & Therapeutics [to 18 October 2014]

Ebola crisis: GSK says vaccine not ready until 2016
BBC 17 October 2014 Last updated at 11:59 BST [Video]
UK pharmaceuticals firm GlaxoSmithKline says any Ebola vaccine it produces will come too late for the current epidemic.
GSK is one of several companies trying to fast-track a vaccine to prevent the spread of Ebola in West Africa.
Dr Ripley Ballou, head of GSK’s Ebola vaccine research, said full data on its safety and efficacy would not be ready until late 2015 and any mass production would not start until 2016.
He told Simon Cox, from the BBC’s File on Four, his fear that without effective controls the epidemic had real potential to “spread to surrounding countries”.

Chimerix: IND authorized for brincidofovir (BCV) for Ebola Virus Disease (EVD)
Chimerix announced that it has worked closely with the FDA to develop a Phase 2 clinical trial protocol to assess the safety, tolerability, and efficacy of brincidofovir in patients who are confirmed to have Ebola Virus Disease. An investigational new drug (IND) application for brincidofovir (BCV) for Ebola Virus Disease (EVD) has been authorized by the FDA. The FDA has authorized a Phase 2 protocol for BCV for EVD to begin immediately. Brincidofovir tablets are available for immediate use in clinical trials.
Full media release: http://ir.chimerix.com/releasedetail.cfm?ReleaseID=876612

China sends thousands of doses of anti-Ebola drug to Africa
Financial Times | 16 October 2014
China has sent thousands of doses of an experimental anti-Ebola drug developed by the Chinese military to Africa. The company manufacturing the drug said it plans to start human clinical trials there soon. Sihuan Pharmaceutical, the private Chinese company that last week purchased the rights to commercialise jk-05 from a branch of the People’s Liberation Army (PLA), said it began manufacturing the drug after it was approved in August as a “special drug for military needs”.
The Chinese military has already sent enough drug to treat 10,000 people in West Africa…The aim is to have the drug on hand in case any of the Chinese medical personnel…fall ill and for use in clinical trials…